MedTrace Logo

SpO2 Validation Study - Philips FAST 2024

NCT06484452 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113

Last updated 2025-09-16

No results posted yet for this study

Summary

Validation study to compare the accuracy of non-invasive Philips SpO2 sensors in detecting blood oxygen levels compared to invasive methods requiring a blood draw and lab analysis.

Conditions

  • Pulse Oximetry

Interventions

DEVICE

No Intervention

No Intervention

Sponsors & Collaborators

  • Philips Clinical & Medical Affairs Global

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-05-06
Primary Completion
2024-08-29
Completion
2024-08-29
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06484452 on ClinicalTrials.gov